SEMDEXA™ (SP-102) is a trademark owned by Semnur Pharmaceuticals, Inc., a wholly-owned subsidiary of Scilex Holding Company. A proprietary name review by the FDA is planned. ZTlido ® is a registered ...

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery ...

The following is a summary of “Metabolic complications and clinical outcomes of non-functioning adrenal incidentalomas: a ...

Fintel reports that on April 8, 2025, William Blair initiated coverage of Ocular Therapeutix (NasdaqGM:OCUL) with a ...

Key points A 47-year-old French-speaking woman of African descent presented to the emergency department with a 1-week history of severe foot pain and difficulty walking. For the preceding 2 months she ...

Early infection incidence in patients with multiple myeloma following treatment with cilta-cel infusion highlights the ...

Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the ...

Failure to suppress cortisol levels below 50 nmol/l after low dose dexamethasone (0.5 mg every 6 h for eight doses ending at 0300 h, or 1 mg at 2300 h with serum cortisol measured the following ...

Low-dose corticosteroids (such as dexamethasone, 0.125-0.5 mg q.h.s ... Intralesional corticosteroids (such as triamcinolone acetonide, 2.5-10 mg/cc) are frequently effective in treating inflamed ...

2,3 DME is a complication of diabetic retinopathy (DR ... patients who received at least 1 intravitreal injection of ranibizumab biosimilar Ranieyes (0.5 mg) between July 2022 and July 2023, with a ...